University of California San Francisco

Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data.

Garg A, Naik HB, Alavi A, Hazen P, Hsiao JL, Shi VY, Weisman J, Tran T, Rudnik J, Jedrzejczyk A, Pansar I, Kimball AB PMID: 36585607

Melanocytic naevi, melanocytomas and emerging concepts.

Yeh I PMID: 36642570

Spontaneous resolution of intractable prurigo nodularis after subinsular cortex stroke.

Kashem SW, Motzkin JC, Leslie KS PMID: 36687303

Spontaneous resolution of intractable prurigo nodularis after subinsular cortex stroke.

Kashem SW, Motzkin JC, Leslie KS PMID: 36687303

Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.

Williams JC, Alhusayen R, Guilbault S, Hills NK, Ingram JR, Kudlinski MV, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA, Naik HB PMID: 36566748

Time and Distance Cost of Longer Acting Anti-VEGF Therapies for Macular Degeneration: Contributions to Drug Cost Comparisons.

Meer EA, Oh DH, Brodie FL PMID: 36578665

Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001-2018.

Silverberg JI, Chaubal M, Warshaw EM, Maibach HI, Belsito DV, DeKoven JG, Zug KA, Taylor JS, Sasseville D, DeLeo VA, Pratt MD, Reeder MJ, Atwater AR, Fowler JF, Houle MC PMID: 36502370

Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients.

Green M, Feschuk AM, Kashetsky N, Maibach HI PMID: 36517586

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort.

Abuabara K, Eichenfield LF, Bissonnette R, Silverberg JI, Bagel J, Guttman-Yassky E, Thaci D, Simpson EL, Harris JE, Krueger J, Myers DE, Gamelli A, Milutinovic M, Parneix A, Crawford JM, Hildebrand JS, Munoz B, Paller AS PMID: 36521798

Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate.

Léauté-Labrèze C, Frieden I, Delarue A PMID: 36511888